Filter
6001
Filtered Results: 6001
Text search:
burden
of
diseases
Featured
Recommendations
478
New Publications
1462
Language
Document type
No document type
3195
Studies & Reports
1340
Guidelines
639
Strategic & Response Plan
263
Manuals
245
Fact sheets
143
Training Material
74
Situation Updates
28
Resource Platforms
26
Infographics
25
Brochures
9
Online Courses
6
Dashboards/Maps
5
Videos
3
Countries / Regions
Global
373
India
269
Kenya
184
South Africa
149
Western and Central Europe
146
Ethiopia
120
Africa
112
Uganda
106
Latin America and the Carribbean
105
Nigeria
103
Sierra Leone
92
Liberia
89
Nepal
85
Tanzania
85
Malawi
85
Zambia
76
Bangladesh
75
Ghana
72
Rwanda
67
Ukraine
65
Myanmar / Burma
62
Eastern Europe
62
Syria
58
Namibia
58
Asia
51
South–East Asia Region
49
Philippines
44
Congo, Democratic Republic of
38
Zimbabwe
38
Mozambique
38
Lesotho
36
Cambodia
34
East and Southern Africa
34
South Sudan
33
Russia
33
Indonesia
32
West and Central Africa
29
Brazil
28
Guinea
24
Botswana
24
Senegal
22
Germany
22
Eastern Europe and Central Asia
22
Haiti
20
Pakistan
20
Middle East and North Africa
20
Eswatini/ Swaziland
18
Yemen
17
Burkina Faso
15
Cameroon
15
Sudan
15
Venezuela
15
North America
14
Afghanistan
13
Colombia
13
Western Pacific Region
13
USA
12
Somalia
11
Thailand
10
Central African Republic
10
Vietnam
10
Jordan
9
Benin
9
Peru
8
Albania
8
Tajikistan
8
Iraq
7
Argentina
7
Madagascar
7
Chile
7
Moldova
7
Mali
6
Lebanon
6
North Macedonia
6
Ecuador
6
Sri Lanka
6
Paraguay
6
Southern Africa
6
Laos
6
Georgia
6
Turkey
5
Mexico
5
Palestine
5
Iran
5
Kyrgyzstan
5
Jamaica
5
Saudi Arabia
4
Egypt
4
China
4
Burundi
4
Libya
4
Angola
4
Armenia
4
Timor Leste/ East Timor
4
Guinea-Bissau
3
Greece
3
Poland
3
Romania
3
Turkmenistan
3
Mauritius
3
United Kingdom
3
Belarus
3
Côte d’Ivoire / Ivory Coast
2
Chad
2
Papua New Guinea
2
Switzerland
2
El Salvador
2
Other region
2
Bhutan
2
Djibouti
2
Canada
2
Qatar
2
Kazakhstan
2
Gabon
2
Tunisia
2
Bosnia and Herzegovina
2
Morocco
1
Niger
1
Togo
1
Gambia
1
Ireland
1
Hungary
1
Honduras
1
Bolivia
1
Guatemala
1
North Korea
1
Mongolia
1
Bulgaria
1
Estonia
1
Slovakia
1
Japan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Portugal
1
Spain
1
Morocco
1
Azerbaijan
1
Israel
1
Barbados
1
Authors & Publishers
Publication Years
Category
Countries
2175
Clinical Guidelines
533
Public Health
509
Women & Child Health
218
Key Resources
183
Capacity Building
73
Pharmacy & Technologies
37
Annual Report MEDBOX
2
General Guidelines
1
Protection & Security
1
Toolboxes
HIV
516
TB
508
Mental Health
488
COVID-19
418
NCDs
299
Planetary Health
276
AMR
230
NTDs
216
Disability
159
Global Health Education
139
Caregiver
134
Conflict
124
Rapid Response
121
Refugee
81
Ebola
80
Health Financing Toolbox
79
Pharmacy
60
Natural Hazards
43
Polio
31
Cholera
28
Zika
19
Social Ethics
18
Specific Hazards
15
South Sudan
1
Health Financing
1
This is an update (third edition) of the BACPR Standards & Core Components and represents current evidence-based best practice and a pragmatic overview of the structure and function ... Cardiovascular Prevention and Rehabilitation Programmes (CPRPs) in the UK. The previously described seven standards have now been reduced to six but without sacrificing any of the key elements and with a greater emphasis placed on measurable clinical outcomes, audit and certification. Similarly, the second edition provided an overview of seven core components felt to be essential for the delivery of quality prevention and rehabilitation, and this too has been reduced to six. The interplay between cardio-protective therapies and medical risk factors is almost impossible to disentangle for the vast majority of patients and even if specific drug therapies are deployed exclusively for risk factor modulation, the indirect effect will also be cardio-protective. Thus, these have been combined into a single core component – medical risk management.
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organ...
SADC Communicable Disease Project
Component 5: Scaling-up Child and Adolescent HIV, TB and Malaria Continuum of Care and Support
DRAFT POST REGIONAL CONSENSUS AND VALIDATION MEETING Oct 2012
Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease...
Schistosomiasis is widely recognized as a disease that is socially determined. An
understanding of the social and behavioural factors linked to disease...
Chagas disease is currently endemic and also predicted to be at increased transmission risk under future climate change scenarios. Similarly, an expansion of areas in the United States at increased ...
Immunization in the context of COVID-19 pandemic
recommended
Immunizations are an essential health service that protect susceptible individuals from vaccine-preventable diseases (VPD).2 By providing timely immunizations, individuals and communities remain protected and the likelihood ... a VPD outbreak decreases
This publication is available in Arabic, Chinese, English, French, Russian and Spanish
In the time of coronavirus disease (COVID-19), sex and drug use will continue, regardless of physical distancing orders and policies. People who pr...
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects ... a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial resistance occurs naturally but misuse of antibiotics in human and animals significantly accelerates the process of developing antimicrobial resistance. In fact, antimicrobial resistance refers to the resistance of a microorganism to one or more antimicrobial drugs which had been previously sensitive to these drugs. Antimicrobial resistance can occur in a wide variety of pathogens including bacteria, parasites, viruses, fungi, and cancer cells and may threaten the life of every person, in every age, and in every country
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leish...
Management of Diabetes Mellitus-Tuberculosis
recommended
1st edition
This resource provides practical guidance for front line health workers responsible for the diagnosis, management and care of patients with these two diseases. Published in collaboratio...
Many of the countries that faced cholera outbreaks in 2022 were badly affected by extreme weather events.
As the climate emergency worsens, human displacement will intensify, along with droughts and flooding – all
conditions that give rise to ch...
A framework for action provides a guide for those involved in the development of the multisectoral action plan. It starts with a wide-ranging vision and, through a series of increasingly specific in...
The African Region has been experiencing unprecedented health challenges due to the Coronavirus disease 2019 (COVID-19) pandemic, which have compounded the already difficult task the Region was facing in moving towards universal health coverage (UHC...
Schistosomiasis is a helminthic infection and one of the neglected tropical diseases (NTDs). It is caused by blood flukes of the genus Schistosoma....
Mosquitoes, flies, bugs and other vectors transmit viruses, parasites and bacteria that infect millions of people globally. They cause many diseases, including malaria, dengue, leishmaniases, Chagas...
The study collected data on the impact of HIV-related diseases on income, revenues, economic dependency, consumption, education, health, food security, stigma, discrimination, quality ... life, and migration. The study also assessed people living with chronic diseases in order to compare the impact of living with HIV/AIDS with the impact of living with a chronic disease.
Stigma, discrimination, and socio-economic exclusion continue to affect the rights and socio-economic opportunities of people living with HIV in Myanmar. Households with a family member who has HIV, have lower incomes, fewer assets and lower home-ownership, compared to households that are not affected by HIV. They also have more household debt, and their families pay a higher rate of interest compared to families not affected by HIV.
Stigma, discrimination, and socio-economic exclusion continue to affect the rights and socio-economic opportunities of people living with HIV in Myanmar. Households with a family member who has HIV, have lower incomes, fewer assets and lower home-ownership, compared to households that are not affected by HIV. They also have more household debt, and their families pay a higher rate of interest compared to families not affected by HIV.
PLoS Negl Trop Dis 14(1): e0007999. January 30, 2020 is the first-ever World Neglected Tropical Diseases Day (World NTD Day), a day when we celebrate the achievements made towards control of the wor...
The main objective of the malaria prevention and control programme in Somalia is to prevent mortality and reduce morbidity due to malaria. The groups most vulnerable to the disease, children aged un...
